| Literature DB >> 27294907 |
Narjara Silveira1, Julia Saar2,3, Alan Diego C Santos4, Andersson Barison5, Louis P Sandjo6, Marcel Kaiser7,8, Thomas J Schmidt9, Maique W Biavatti10.
Abstract
From the aerial parts of Acmella ciliata (H.B.K.) Cassini (basionym Spilanthes ciliata Kunth; Asteraceae), three alkamides were isolated and identified by mass- and NMR spectroscopic methods as (2E,6E,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol, (1)), N-(2-phenethyl)-2E-en-6,8-nonadiynamide (2) and (2E,7Z)-6,9-endoperoxy-N-isobutyl-2,7-decadienamide (3). While 1 and 2 are known alkamides, compound 3 has not been described until now. It was found that the unusual cyclic peroxide 3 exists as a racemate of both enantiomers of each alkamide; the 6,9-cis- as well as the 6,9-trans-configured diastereomers, the former represents the major, the latter the minor constituent of the mixture. In vitro tests for activity against the human pathogenic parasites Trypanosoma brucei rhodesiense and Plasmodium falciparum revealed that 1 and 3 possess activity against the NF54 strain of the latter (IC50 values of 4.5 and 5.1 µM, respectively) while 2 was almost inactive. Compound 3 was also tested against multiresistant P. falciparum K1 and was found to be even more active against this parasite strain (IC50 = 2.1 µM) with considerable selectivity (IC50 against L6 rat skeletal myoblasts = 168 µM).Entities:
Keywords: Acmella ciliata; Asteraceae; Plasmodium falciparum; alkamide; antiplasmodial activity; endoperoxide; jambu
Mesh:
Substances:
Year: 2016 PMID: 27294907 PMCID: PMC6274185 DOI: 10.3390/molecules21060765
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of the isolated alkamides.
1H-NMR data (CDCl3, 600 MHz) for compounds 3a and 3b.
| Position | 3a | 3b |
|---|---|---|
| δH, Mult. ( | δH, Mult. ( | |
| 5.82 | 5.82 | |
| 6.81 | 6.81 | |
| 2.32 | 2.32 | |
| 2.36 | 2.36 | |
| 1.69 | 1.67 | |
| 1.87 | 1.87 | |
| 4.38 | 4.59 | |
| 5.83 | 5.78 | |
| 5.86 | 5.83 | |
| 4.66 | 4.70 | |
| 1.23 | 1.20 | |
| 3.14 | 3.14 | |
| 1.80 | 1.80 | |
| 0.92 | 0.92 | |
| 0.92 | 0.92 |
The corrected multiplicities in the 1H-NMR spectra were established with the aid of FOMSC3 software [13].
13C-NMR data (CDCl3, 150 MHz) for compounds 3a and 3b.
| Position | 3a | 3b | ||
|---|---|---|---|---|
| δC | HMBC | δC | HMBC | |
| 166.0 | 165.9 | |||
| 124.4 | C-1, C-4 | 124.4 | C-1, C-4 | |
| 143.3 | C-1, C-2, C-4, C-5 | 143.2 | C-1, C-2, C-4, C-5 | |
| 27.9 | C-2, C-3, C-5, C-6 | 27.5 | C-2, C-3, C-5, C-6 | |
| C-2, C-3, C-5, C-6 | C-2, C-3, C-5, C-6 | |||
| 31.5 | C-3, C-4, C-6, C-7 | 31.0 | C-3, C-4, C-6, C-7 | |
| C-3, C-4, C-6, C-7 | C-3, C-4, C-6, C-7 | |||
| 77.2 | C-4, C-5, C-7, C-8 | 76.8 | C-4, C-5, C-7, C-8 | |
| 127.0 | C-6, C-9 | 127.2 | C-6, C-9 | |
| 129.3 | C-6, C-9 | 129.5 | C-6, C-9 | |
| 74.3 | C-7, C-8, C-10 | 74.2 | C-7, C-8, C-10 | |
| 18.1 | C-8, C-9 | 17.7 | C-8, C-9 | |
| 46.8 | C-1, C-2’, C-3’, C-4’ | 46.7 | C-1, C-2’, C-3’, C-4’ | |
| 28.5 | C-1’, C-3’, C-4’ | 28.5 | C-1’, C-3’, C-4’ | |
| 20.1 | C-1’, C-2’, C-4’ | 20.1 | C-1’, C-2’, C-4’ | |
| 20.1 | C-1’, C-2’, C-3’ | 20.1 | C-1’, C-2’, C-3’ | |
Figure 2Key HMBC correlations for compound 3.
Calculated and experimental chemical shift values and differences for protons at the endoperoxide ring of compound 3. Upfield shifts comparing the first and second columns of calculated and experimental data, respectively, are colored in blue, downfield shifts in red.
| Position H- | Calc. Δ | Δδ Calc | Exp. Δ | Δδ Exp | ||
|---|---|---|---|---|---|---|
| 6 | 6 | Major Isomer | Minor Isomer | |||
| 5a | 1.426 | 1.486 | 0.059 | 1.873 | 1.873 | 0.000 |
| 5b | 2.149 | 1.510 | −0.638 | 1.693 | 1.669 | −0.024 |
| 6 | 4.030 | 4.622 | 0.591 | 4.377 | 4.586 | 0.209 |
| 7 | 6.098 | 5.859 | −0.240 | 5.830 | 5.782 | −0.048 |
| 8 | 6.032 | 5.950 | −0.082 | 5.860 | 5.830 | −0.030 |
| 9 | 4.807 | 4.849 | 0.042 | 4.663 | 4.696 | 0.033 |
| 10 | 0.982 | 0.998 | 0.016 | 1.232 | 1.203 | −0.029 |
Figure 3Hypothetical routes of formation for the stereoisomers of compound 3.
Figure 4Proposed fragmentation mechanism of the endoperoxide alkamide (m/z 254).
In vitro antiparasitic activity IC50 values in µg/mL and cytotoxicity (L6 rat skeletal myoblasts) of alkamides 1–3. Mean values are also reported in µM (in brackets) for easier comparison between compounds.
| Compound | L6 | |||
|---|---|---|---|---|
| 2.88 ± 0.06 (13.0) | 0.99 ± 0.12 (4.5) | n.t. | 39.9 ± 1.9 (180.3) | |
| 17.1 ± 2.3 (68.1) | 22.1 ± 4.0 (88.0) | n.t. | 60.1 ± 9.4 (239.2) | |
| 5.60 ± 0.67 (13.0) | 1.29 ± 0.20 (5.1) | 0.54 ± 0.14 (2.1) | 42.6 ± 1.7 (168.2) | |
| Pos. contr. | 0.004 ± 0.001 a | 0.002 ± 0.001 b | 0.09 ± 0.006 b | 0.004 ± 0.001 c |
a melarsoprol; b chloroquine; c podophyllotoxin.
Figure 5Flow chart for the isolation of the compounds 1–3.